The Tampa Bay High-Risk Skin Cancer Clinic is built for patients facing aggressive, recurrent, or transplant-associated skin cancers that require close monitoring and a more strategic treatment model. This program is designed for individuals whose disease behavior may be accelerated by immunosuppression, prior high-risk pathology, multiple tumors, or a history of recurrence.
Rather than treating lesions in isolation, this clinic takes a broader and more proactive approach. Each patient’s care plan is shaped by tumor biology, immune status, treatment history, and future risk. The goal is not only to remove current cancers, but to reduce recurrence, improve early detection, and create a long-term management strategy that supports better outcomes over time.
Care is led by a fellowship-trained Mohs surgeon with transplant dermatology experience and advanced focus in high-risk cutaneous oncology.
When needed, care is coordinated across dermatology, medical oncology, surgical oncology, radiation oncology and transplant teams to ensure a more complete treatment and surveillance plan.
Clinical decisions are shaped by risk factors such as tumor pathology, recurrence history, immune status, and evolving evidence-based prevention protocols.
This program is structured for ongoing management, with follow-up protocols designed to detect new lesions early and reduce future disease burden.
This program is intended for patients whose skin cancer risk, recurrence pattern, or immune status requires more specialized oversight.
Begin with a structured physician consultation focused on goals, history, and planning.
Move into a guided treatment plan which may include prescription support and counseling.
Return for follow-ups that help maintain accountability and optimize the plan over time.
Four Core Elements of High-Risk Skin Cancer Management
Individualized assessment based on tumor biology, immune status, pathology, and prior clinical history to define current risk and guide treatment planning.
Mohs surgery for high-risk tumors, field therapy, adjunctive treatment planning, and integration of emerging therapies when clinically appropriate.
Chemoprevention strategies, field cancerization management, UV counseling, and behavioral modification tailored to long-term disease control.
Structured follow-up schedules, early detection protocols, and recurrence prevention strategies designed for ongoing risk reduction.
Conditions Commonly Managed in This Program
These conditions often require more than standard treatment alone. Our clinic evaluates both the immediate lesion and the broader clinical pattern to create a more durable management strategy.
Amy. S. Ross, MD is a fellowship-trained Mohs surgeon and double board certified in Dermatology and Micrographic Dermatologic Surgery. Her clinical approach centers on the management of aggressive and complex skin cancers, particularly in immunosuppressed patients, where disease behavior is often accelerated and outcomes depend on early, precise intervention.
Trained at Vanderbilt University Medical Center in a multidisciplinary environment that included a dedicated transplant dermatology clinic, Dr. Ross brings an integrated, team-based approach to patient care. She collaborates across specialties when needed and applies advanced surgical, diagnostic, and surveillance strategies tailored to each patient’s individual risk profile.
As a member of the International Immunosuppression & Transplant Skin Cancer Collaborative, Dr. Ross remains closely aligned with evolving research and emerging treatment paradigms. She emphasizes data-driven decision-making, using risk stratification tools, longitudinal surveillance, and preventative strategies to reduce recurrence and improve long-term outcomes.
Her program is designed to provide comprehensive, high-touch care for patients with advanced, recurrent, or high-risk skin cancers, delivering not only treatment, but a long-term strategy for lifelong skin cancer management.
Mohs Micrographic Surgery and Cosmetic Dermatologic Surgery
Dr. Divya Aickara is a fellowship-trained Mohs surgeon and double board certified in Dermatology and Micrographic Dermatologic Surgery with a clinical focus on the management of high-risk and complex skin cancers. She completed her dermatology residency at the Jackson Memorial Hospital and University of Miami and fellowship training in Mohs Micrographic Surgery with the Skin Cancer Institute and Hollywood Dermatology in Fort Lauderdale, FL.
Dr. Aickara has experience caring for patients with aggressive cutaneous malignancies, including immunosuppressed and high-risk populations, using a collaborative and patient-centered approach to treatment. Her practice emphasizing a multidisciplinary approach, individualized care, and long-term surveillance strategies aimed at optimizing outcomes and preserving quality of life.
She is committed to providing compassionate, evidence-based care while helping patients navigate the complexities of skin cancer treatment and prevention.
Priority scheduling for urgent or concerning lesions
Clear communication and follow-up planning
Co-management with transplant and oncology teams when appropriate
Request an evaluation at our Clearwater, Palm Harbor, Palmer Ranch, SOHO, or Westchase locations for advanced, recurrent, or transplant-associated skin cancer care with a specialized long-term management approach.
Request a consultation with Dr. Ross. If patient meets initial qualifications, we will contact you to finalize any additional details.
